Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  6.40 0.45% 1,416.00 1,417.60 1,418.20 1,419.20 1,406.40 1,408.60 3,445,960 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 15.1 71,240

Glaxosmithkline Share Discussion Threads

Showing 27701 to 27723 of 27725 messages
Chat Pages: 1109  1108  1107  1106  1105  1104  1103  1102  1101  1100  1099  1098  Older
DateSubjectAuthorDiscuss
24/7/2021
16:38
spud: you said "consumer division will probably be taken out".... That is my very point! The more profit it makes NOW the better price we will get for it. To my mind the URGENT profit is the consumer profit because its basically up for sale. The pharma side really needs good trial results and good promises of future growth. The consumer side needs good growth story NOW as its up for sale NOW.
netcurtains
24/7/2021
16:30
It a Sun exclusive story..........covid built on fraud htTps://www.thesun.co.uk/news/15614601/covid-testing-firm-dumping-kits/ Bernie's Tweets @BernieSpofforth If this is actually happening then it needs a full investigation by the Police & the head of Gov procurement needs to lose their job. We’ve sacrificed far to much because incompetence, criminal activity and greed is allowed to continue. https://twitter.com/BernieSpofforth/status/1418478502391787521
jimarilo
24/7/2021
16:17
Consumer division will probably be taken out before it gains any meaningful traction. spud
spud
24/7/2021
14:24
What will determine the valuation and future share price is what both companies are worth, with the new Pharma being the most valuable of the two. Your original point was that higher consumer sales would boost the share price That would only be true if accompanied by better vaccine and pharma sales. If the latter are poor, the consumer sales are unlikely to plug the gap.
alex1621
24/7/2021
07:38
In the split of the two companies next year, what really is going to count is how much is the toothpaste company worth...... The more sun blocker and toothpaste that are sold the more GSK will get for that part of the company and thus the more money our shares will be worth. In a sense we're selling a toothpaste company and we want as much money for it as possible. That is the name of the game for the next two years.
netcurtains
24/7/2021
01:15
Your points make no sense.
alex1621
23/7/2021
19:05
totally disagree. Unilever is the 2nd biggest company on the FTSE100 by market cap. and Reckitt Benckiser 12th Like many people you're getting blinded by tech and drugs. What really counts is the profit made by toothpaste and sun cream. Of course AZN is number ONE on the UK stock market today but is that because people have got covid19 on the brain? I think they do.
netcurtains
23/7/2021
18:47
It's not that material if the other two businesses are underperforming. Toothpaste sales don't move the needle.
alex1621
23/7/2021
16:41
alex1621: what percentage of the business is the consumer side? If its accounts for 25% or more, then any good growth in consumer side is going to boost the entire company.
netcurtains
23/7/2021
16:37
Drop in the ocean. We need encouraging results from Pharma and vaccines together with a positive forward outlook.
alex1621
23/7/2021
14:19
alex1621: Well we know that "food" sales have been doing well. Since household good are in the shelves in the same super markets its probable that Glaxo's consumer products (toothpaste etc) have been doing well. And sunburn products? Come on they must be doing well!!!! Https://pk-consumerhealthcare.gsk.com/en-gb/products/consumer-healthcare-products/skin-health/spectraban/
netcurtains
23/7/2021
11:58
Bear in mind there is an update on Wednesday next week. So don't expect much activity. The only people buying or selling heavily this side of an update have inside information.
alex1621
23/7/2021
10:59
come on glaxo boy.....
netcurtains
23/7/2021
08:00
..and the horses are off!
netcurtains
22/7/2021
21:21
I see monty has infected the ULVR board.
spoole5
22/7/2021
21:11
No Short interest in GSK currently. spud
spud
22/7/2021
19:52
sorry rant over.
netcurtains
22/7/2021
18:15
Monty, there's no UK equivalent to the SEC's 13F filing requirement just the need to register a holding over 3% of a listed company shares
tradermichael
22/7/2021
17:39
TraderYou may know, 13F filings have to be made no more than 45 days from the last quarter, seeing Elliott Management are American outfit, are they exempt from reporting overseas positions, someone said they are?
montyhedge
22/7/2021
16:54
Also 5 star rating from Mandy Rice-Davis riding school.
glasgow13
22/7/2021
16:39
You forgot the Phd from Trump University.
alex1621
22/7/2021
16:37
Is even this one qualified to sell toothpaste and paracetamol? "Brian has an undergraduate degree in Electrical Engineering from Union College in Schenectady, New York and an MBA in Finance from University of Cincinnati."
tradermichael
22/7/2021
14:54
Oh dear stuck with useless Emma Pharm side post demerger it seems... "Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company"
geckotheglorious
Chat Pages: 1109  1108  1107  1106  1105  1104  1103  1102  1101  1100  1099  1098  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210724 18:15:56